Limit search to available items
Nearby Subjects are:
Result Page   Prev Next
Add Marked to Bag Add All On Page Add Marked to My Lists
Mark   Year Entries
Drug and Narcotic Control -- legislation & jurisprudence -- United States -- Periodicals : Journal of GXP compliance (Online)    1
Drug and Narcotic Control -- methods. : Beating drug tests and defending positive results : a toxicologist's perspective / by Amitava Dasgupta  2010 1
Drug and Narcotic Control -- organization & administration. : European studies on drugs and drug policy : selected readings from the 14th International Conference of the European Society for Social Drug Research (ESSD) / edited by Tom Decorte and Dirk Korf  2004 1
Drug and Narcotic Control -- Periodicals : Journal of drug issues (Online)    1
Drug and Narcotic Control -- statistics & numerical data. : Lies, damned lies, and drug war statistics : a critical analysis of claims made by the Office of National Drug Control Policy / Matthew B. Robinson and Renee G. Scherlen  2014 1
Drug and substance abuse: social aspects. : Teaching 'Proper' Drinking? : Clubs and pubs in Indigenous Australia  2017 1
Drug antagonism. : A pharmacology primer : theory, application and methods / Terry Kenakin  2006 1
Drug antagonism -- Research -- Methodology : Drug interaction and lethality analysis / authors, Marshall N. Brunden, Thomas J. Vidmar, Joseph W. McKean  2019 1
Drug antagonism -- Statistical methods : Drug interaction and lethality analysis / authors, Marshall N. Brunden, Thomas J. Vidmar, Joseph W. McKean  2019 1
 

Drug-antibody conjugates -- See Antibody-drug conjugates


  1
 

Drug Approval -- See Also Drugs, Investigational


Drugs which have received FDA approval for human testing but have yet to be approved for commercial marketing. This includes drugs used for treatment while they still are undergoing clinical trials (Treatment IND). The main heading includes drugs under investigation in foreign countries
  1
Drug Approval.   51
Drug approval -- Economic aspects. : Pharmaceutical lifecycle management : making the most of each and every brand / Tony Ellery, Neal Hansen  2012 1
Drug Approval -- economics. : Pharmaceutical lifecycle management : making the most of each and every brand / Tony Ellery, Neal Hansen  2012 1
Drug Approval -- history.   2
Drug Approval -- legislation & jurisprudence.   8
Drug Approval -- methods.   12
 

Drug Approval, New -- See Drug Approval


Process that is gone through in order for a drug to receive approval by a government regulatory agency. This includes any required pre-clinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance of the drug
  1
Drug Approval -- organization & administration.   5
Drug Approval -- Periodicals : Expert opinion on therapeutic patents (Online)    1
  Drug approval process -- 2 Related Subjects   2
 

Drug Approval Processes -- See Drug Approval


Process that is gone through in order for a drug to receive approval by a government regulatory agency. This includes any required pre-clinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance of the drug
  1
Drug approval -- Safety regulations -- United States : FDA's drug review process and the package label : strategies for writing successful FDA submissions / Tom Brody  2017 1
Drug approval -- Statistical methods. : Statistical thinking for non-statisticians in drug regulation / Richard Kay, PhD, Statistical Consultant, RK Statistics Ltd, Honorary Visiting Professor, School of Pharmacy, Cardiff University, UK  2015 1
Drug approval -- United States.   9
 

Drug Approvals -- See Drug Approval


Process that is gone through in order for a drug to receive approval by a government regulatory agency. This includes any required pre-clinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance of the drug
  1
 

Drug Approvals, New -- See Drug Approval


Process that is gone through in order for a drug to receive approval by a government regulatory agency. This includes any required pre-clinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance of the drug
  1
 

Drug Augmentation -- See Drug Synergism


The action of a drug in promoting or enhancing the effectiveness of another drug
  1
 

Drug Augmentations -- See Drug Synergism


The action of a drug in promoting or enhancing the effectiveness of another drug
  1
 

Drug availability -- See Drug accessibility


Here are entered works on patients' practical or economic access to therapeutic drugs. Works on the physiological availability of administered drugs within the body are entered under Drugs--Bioavailability
  1
 

Drug Benefit Plan -- See Insurance, Pharmaceutical Services


Insurance providing for payment of services rendered by the pharmacist. Services include the preparation and distribution of medical products
  1
  Drug Benefit Plans -- 2 Related Subjects   2
 

Drug bioavailability -- See Drugs Bioavailability


Here are entered works on the physiological availability of administered drugs within the body. Works on patients' practical or economic access to therapeutic drugs are entered under Drug accessibility
  1
 

Drug bioscreening -- See Drugs Testing


Here are entered works on testing the effectiveness or safety of drugs. Works on testing to identify the personal use or misuse of drugs are entered under Drug testing. Technical works on chemical analysis to determine the composition or presence of drugs are entered under Drugs--Analysis

--subdivision Testing under individual drugs and groups of drugs; and subdivision Therapeutic use--Testing under individual chemicals and groups of chemicals, e.g. Copper--Therapeutic use--Testing; Insulin--Therapeutic use--Testing
  1
 

Drug Carrier -- See Drug Carriers


Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers
  1
 

Drug carrier systems (Pharmacy) -- See Drug carriers (Pharmacy)


  1
Drug Carriers.   24
Drug Carriers -- administration & dosage. : Polymers as nanocarriers for controlled drug delivery / Marcelo Calderón  2018 1
Drug Carriers -- chemistry. : Polymers as nanocarriers for controlled drug delivery / Marcelo Calderón  2018 1
Drug Carriers -- metabolism. : Transport and delivery of neurotrophic peptides and proteins across the BBB / Weihong Pan  2017 1
Drug Carriers -- methods : Polymeric delivery of therapeutics / Sarah E. Morgan, editor, School of Polymers and High Performance Materials University of Southern Mississippi, Robert Y. Lochhead, editor, School of Polymers and High Performance Materials, University of Southern Mississippi ; sponsored by the ACS Division of Polymer Chemistry  2010 1
Drug Carriers -- pharmacokinetics.   3
Drug Carriers -- pharmacology.   3
 

Drug carriers (Pharmacy) -- See Also the narrower term Microspheres (Pharmacy)


  1
Drug carriers (Pharmacy)   25
Drug carriers (Pharmacy) -- Periodicals : Drug design and discovery (Online)    1
Drug Carriers -- therapeutic use.   3
 

Drug Catalogs as Topic -- See Catalogs, Drug as Topic


Works about lists of drugs for sale
  1
 

Drug chemistry -- See Pharmaceutical chemistry


  1
 

Drug, Chemotherapeutic Anticancer -- See Antineoplastic Agents


Substances that inhibit or prevent the proliferation of NEOPLASMS
  1
Add Marked to Bag Add All On Page Add Marked to My Lists
Result Page   Prev Next